Incidence of Severe Hypothermia and Its Impact on Postoperative Surgical Complications and Time Delay to Adjunct Treatments in Breast Surgery Cancer Patients: A Case-Controlled Study.

Cyrus Motamed,Jean Louis Bourgain,Chaima Dridi,Gregoire Weil

doi:10.3390/jcm10163702

Cyrus Motamed, Jean Louis Bourgain + Show 2 more

Open Access

https://doi.org/10.3390/jcm10163702

Copy DOI

Abstract

Introduction: Unintended postoperative hypothermia frequently occurs upon arrival in the post anesthesia care unit (PACU). As part of our quality assurance program in anesthesia, we regularly monitor the incidence of this complication through our anesthesia information management system (AIMS). In this case-controlled retrospective study, our goal was to detect the incidence of unintended severe hypothermia in our breast surgery cancer patients, and subsequently to analyze the consequence of this complication in terms postoperative cutaneous infection, as well as its impact on further complementary treatment, such as radiotherapy and chemotherapy. Methods: This study was a retrospective analysis conducted through our AIMS system from 2015 through 2019, with extraction criteria based on year, type of surgery (breast), and temperature upon arrival in PACU. A tympanic temperature of less than 36 °C was considered to indicate hypothermia. Severe hypothermia was considered for patients having a temperature lower than 35.2 °C (hypothermic) (n = 80), who were paired using a propensity score analysis with a control group (normothermic) (n = 80) of other breast cancer surgery patients. Extracted data included time of surgery, sex, age, ASA status, and type and duration of the intervention. Results: The mean incidence of hypothermia was 21% from 2015 through 2019. The body mass index (BMI) was significantly lower in the hypothermia group before matching, 23.5 ± 4.1 vs. 26.4 ± 6.1 kg/m2 in normothermic patients (p < 0.05). The hypothermia group also had significantly fewer monitoring and active warming devices. No difference was noted for wound complications. Time to complementary chemotherapy and or radiotherapy did not differ between groups (52 ± 21 days in group hypothermia vs 49 ± 22 days in the control group). Conclusion: Severe intraoperative hypothermia remains an important quality assurance issue in our breast surgery cancer patients, but we could not detect any long-term effect of hypothermia.

Highlights

Perioperative hypothermia increases perioperative morbidity [1,2], including postoperative wound infections, that, because of their frequency and severity, are a significant risk for surgery patients [3]
We previously reported an incidence of mild hypothermia in our institution as part of our quality assurance program in anesthesia [7,8]
We did not evaluate any other related complications specific to our surgical cancer patients. This quality assurance program largely relies on our Anesthesia Information Management System (AIMS), which permits the regular and easy monitoring of different quality assurance anesthesia indicators to improve our practice [8,9]

Summary

Introduction

Perioperative hypothermia increases perioperative morbidity [1,2], including postoperative wound infections, that, because of their frequency and severity, are a significant risk for surgery patients [3]. In addition to intraoperative warming, prewarming is reported to significantly contribute to the maintenance of normothermia, decreasing the incidence of surgical site infection [4]. We previously reported an incidence of mild hypothermia in our institution as part of our quality assurance program in anesthesia [7,8]. We did not evaluate any other related complications specific to our surgical cancer patients. This quality assurance program largely relies on our Anesthesia Information Management System (AIMS), which permits the regular and easy monitoring of different quality assurance anesthesia indicators to improve our practice [8,9]

Objectives

Methods

Results

Discussion

Conclusion